130 related articles for article (PubMed ID: 22722457)
1. Prognostic analysis of limited-stage small cell lung cancer after chemoradiotherapy.
Su J; Zhu S; Liu Z; Jing S; Shen W; Li J
Onkologie; 2012; 35(6):362-7. PubMed ID: 22722457
[TBL] [Abstract][Full Text] [Related]
2. A study of elderly patients with limited-stage small-cell lung cancer after combined chemoradiotherapy.
Su J; Zhu S; Liu Z; Li J; Shen W; Li R
Am J Ther; 2014; 21(5):371-6. PubMed ID: 22975663
[TBL] [Abstract][Full Text] [Related]
3. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer.
Sas-Korczynska B; Sokolowski A; Korzeniowski S
Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659
[TBL] [Abstract][Full Text] [Related]
4. Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response.
Fujii M; Hotta K; Takigawa N; Hisamoto A; Ichihara E; Tabata M; Tanimoto M; Kiura K
Lung Cancer; 2012 Oct; 78(1):107-11. PubMed ID: 22858447
[TBL] [Abstract][Full Text] [Related]
5. Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.
El Sharouni SY; Kal HB; Barten-Van Rijbroek A; Struikmans H; Battermann JJ; Schramel FM
Anticancer Res; 2009 Dec; 29(12):5219-24. PubMed ID: 20044639
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of effectiveness and safety of different treatment modes for limited-stage small cell lung].
Shen J; Wang LH; Zhang FQ; Wang MZ; Li Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):343-7. PubMed ID: 23827076
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
8. Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma.
Wong AT; Rineer J; Schwartz D; Becker D; Safdieh J; Osborn V; Schreiber D
Clin Lung Cancer; 2017 Mar; 18(2):207-212. PubMed ID: 27686970
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
[TBL] [Abstract][Full Text] [Related]
10. Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy.
Socha J; Guzowska A; Tyc-Szczepaniak D; Wierzchowski M; Sprawka A; Szczesna A; Kepka L
J BUON; 2015; 20(1):146-57. PubMed ID: 25778310
[TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : A single-centre retrospective study.
Sas-Korczyńska B; Łuczyńska E; Kamzol W; Sokołowski A
Strahlenther Onkol; 2017 Feb; 193(2):141-149. PubMed ID: 27785518
[TBL] [Abstract][Full Text] [Related]
12. Small-cell lung cancer: prognostic factors and changing treatment over 15 years.
Gaspar LE; McNamara EJ; Gay EG; Putnam JB; Crawford J; Herbst RS; Bonner JA
Clin Lung Cancer; 2012 Mar; 13(2):115-22. PubMed ID: 22000695
[TBL] [Abstract][Full Text] [Related]
13. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
Schild SE; Bonner JA; Hillman S; Kozelsky TF; Vigliotti AP; Marks RS; Graham DL; Soori GS; Kugler JW; Tenglin RC; Wender DB; Adjei A
J Clin Oncol; 2007 Jul; 25(21):3124-9. PubMed ID: 17634491
[TBL] [Abstract][Full Text] [Related]
14. Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial.
Sheikh H; Colaco R; Lorigan P; Blackhall F; Califano R; Ashcroft L; Taylor P; Thatcher N; Faivre-Finn C
Lung Cancer; 2011 Oct; 74(1):75-9. PubMed ID: 21353720
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of downstaging in patients with limited-disease small-cell lung cancer.
Go SI; Keam B; Kim TM; Lee SH; Kim DW; Kim HJ; Wu HG; Chung DH; Heo DS
Clin Lung Cancer; 2014 Mar; 15(2):e1-6. PubMed ID: 24356090
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in small cell lung cancer].
Torun E; Fidan A; Cağlayan B; Salepçi T; Mayadağli A; Salepçi B
Tuberk Toraks; 2008; 56(1):22-9. PubMed ID: 18330751
[TBL] [Abstract][Full Text] [Related]
17. [Combined modality therapy for small cell lung cancer patient with limited stage disease].
Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of superior sulcus tumors: results and prognostic factors.
Demir A; Sayar A; Kocaturk CI; Gunluoglu MZ; Akýn H; Metin M; Cansever L; Olcmen A; Dincer SI; Bedirhan MA; Gurses A
Thorac Cardiovasc Surg; 2009 Mar; 57(2):96-101. PubMed ID: 19241311
[TBL] [Abstract][Full Text] [Related]
19. Induction concurrent chemoradiotherapy compared with induction radiotherapy for superior sulcus non-small cell lung cancer: a retrospective study.
Li J; Dai CH; Shi SB; Bao QL; Yu LC; Wu JR
Asia Pac J Clin Oncol; 2010 Mar; 6(1):57-65. PubMed ID: 20398039
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of treatment outcomes in two patient cohorts (2004-2005 and 2007-2008) with limited and extensive disease small-cell lung cancer].
Hermes A; Waschki B; Gatzemeier U; Reck M
Pneumologie; 2011 Apr; 65(4):203-7. PubMed ID: 21267814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]